We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0A4W Acadia Pharmaceuticals Inc

0.00 (0.00%)

Acadia Pharmaceuticals Financial Summary

The current 0A4W market cap is 0. The company's latest EPS is USD -0.3733 and P/E is -45.73.

Year End 31 December 2023 20192020202120222023
Total Revenue 339.08M441.76M484.15M517.24M726.44M
Operating Income -246.55M-286.59M-170.44M-223.6M-73.38M
Net Income -235.26M-281.58M-167.87M-215.98M-61.29M
Year End 31 December 2023 20192020202120222023
Total Assets 783.18M782.62M700.12M587.81M748.96M
Total Liabilities 84.05M155.61M159.23M187.4M317.2M
Total Equity 699.14M627.01M540.89M400.41M431.76M

Cash Flow

Year End 31 December 2023 20192020202120222023
Operating -151.13M-136.17M-125.66M-114.04M16.7M
Investing -165.84M192.51M-71.1M73.24M32M
Financing 371.85M81M18.16M8.2M25.13M
Market Cap 0
Price to Earnings Ratio -45.73
Price to Sales Ratio 3.86
Price to Cash Ratio 14.86
Price to Book Ratio 6.49
Dividend Yield -

Share Statistics

Shares Outstanding 164.18M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0 (0%)

Company Info

Company Name Acadia Pharmaceuticals Inc
Address 251 little falls drive
wilmington, delaware 19808
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock